Cytori Therapeutics Inc.


in
Cytori Therapeutics Inc. reported earnings results for the fourth quarter and year ended December 31, 2007. For the fourth quarter, the company reported net loss of $10,679,000 or $0.44 basic and diluted net loss per common share compared to net loss of $1,911,000 or $0.10 basic and diluted net loss per common share for the same period last year. Product revenues for the fourth quarter of 2006 are $363,000.